how dangerous is tirzepatide vs. Retatrutide: Key Differences Explained Tirzepatide Dosage Chart & Dosing

It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors

Others reserve the term for ultra-low protocols beginning at 0.125 mg to 0.5 mg weekly

If you have been off for a full week, consider dropping back by 1 to 2 mg daily for the first few days, then returning to your regular dose

At least with exenatide, a GLP-1R-mediated protein phosphorylation in HAP has been reported (Wallner et al

Lilly in August began sending cease-and-desist letters to telehealth companies, wellness centers and medical spas selling compounded versions of Zepbound and Mounjaro